Elkedonia
elkedonia.com
Actively hiring
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$11.9M
1 round on record
Latest round
$11.9M
Seed · Jun 2025 · 15 mo ago
Team
51-200
employees, estimated range
Backers
2
Angelini Ventures, Kurma Partners
The money's age
Due for its next round
15 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 10, 2025
Raised a round Seed $11.9M
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Jun 2025 | $11.9M | — | pharmtech.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Angelini Ventures 
Kurma Partners Similar startupsby what they do, their industry and backers
Developing transformative medicines for neurological and mental health disorders.
Struggling with breakup, relationship issues, loneliness, anxiety, depression or mental health? Get Emotional Support on Clarity App now.
Treating depression through gameplay. We revolutionize depression treatment through engaging game-based Digital Therapeutics (DTx).
Handspring Health provides children and families with essential mental health treatment, counseling, and lifelong skills that empower their…
Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly…
Damona Pharmaceuticals is developing precision neuromedicines to reverse cognitive deficits associated with brain disorders.associated with…
News
Elkedonia veut révolutionner le traitement des dépressions résistantes
En s'attaquant à une protéine clé de la dépression, Elkedonia entend accélérer le traitement des dépressions résistantes tout en améliorant considérablement la qualité de vie des patients. La jeune biotech reçoit le Prix de la scale-up de l'année 2026, 34
Read more
Report
Elkedonia strengthens its Leadership Team
We are thrilled to announce the strengthening of Elkedonia's Leadership Team! As we accelerate the development of our breakthrough program for treatment-resistant depression, we are proud to welcome three experienced leaders into their new roles: Anna Qua
Read more
Report
Delphine Charvin and Mélanie Rouillier shortlisted for the 2026 EY Entrepreneur of the Year Award
Delphine Charvin, founding CEO, and Mélanie Rouillier, founding COO, have been selected by EY Grand Est as candidates for the 2026 Entrepreneur of the Year Award. The post Delphine Charvin and Mélanie Rouillier shortlisted for the 2026 EY Entrepreneur of
Read more
Report
Elkedonia contributes to the EBRAINS Roadmap 2026-2036
Elkedonia contributes to the EBRAINS 10-year roadmap, bringing its precision psychiatry drug development expertise to the future of European brain research. The post Elkedonia contributes to the EBRAINS Roadmap 2026-2036 appeared first on Elkedonia.
Read more
Report
Elkedonia strengthens Board of Directors with appointment of Pierre d'Epenoux as Independent Chairman
Appointment strengthens Elkedonia
Read more
Report
Elkedonia strengthens Board of Directors with appointment of Pierre d'Epenoux as Independent Chairman
Elkedonia appoints industry veteran Pierre d'Epenoux, former CEO of ImCheck Therapeutics, as Independent Chairman to strengthen its Board of Directors. This leadership addition supports the company's growth as it advances its innovative, non-hallucinogeni
Read more
Report
Elkedonia strengthens Board of Directors with appointment of Pierre d'Epenoux as Independent Chairman
Appointment strengthens Elkedonia
Read more
Report
Elkedonia invited to the French Embassy in London for the UK-French Mental Health Biomarkers consortium
Elkedonia joined the UK-French Mental Health Biomarkers consortium at the French Embassy in London, strengthening cross-border collaboration on mental health. The post Elkedonia invited to the French Embassy in London for the UK-French Mental Health Bioma
Read more
Report
Delphine Charvin Selected for the 6th Galion Project x ConnectHers Cohort
Elkedonia's founding CEO has been selected to join the prestigious program by BNP Paribas and The Galion Project, an honor that places her among an inspiring community of leading founders. This selection highlights Delphine's leadership and strengthens El
Read more
Report
Elkedonia at the 2nd Mental Health Research Day by the Alliance and the FRM
Jocelyne Caboche took part in the second edition co-organised by the Alliance pour la Santé Mentale and the Fondation pour la Recherche Médicale, contributing to a working group on mental health research. The post Elkedonia at the 2nd Mental Health Resear
Read more
Report
Show more news
Financials
Total raised
$11.9M
Latest round
Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Seed | 2025 | $11.9M | Details |